These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 31847670

  • 1. Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats.
    Yang T, Zheng TH, Zhao Q, Liu W, Li SP, Tao YY, Wang CH, Liu CH.
    Pharm Biol; 2020 Dec; 58(1):1-7. PubMed ID: 31847670
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
    Yang T, Liu S, Zheng TH, Tao YY, Liu CH.
    J Ethnopharmacol; 2015 May 26; 166():305-12. PubMed ID: 25794805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of Fuzheng Huayu recipe on CYP450 isozymes in normal and liver fibrosis rats].
    Zheng TH, Liu W, Li SP, Yang T, Wang CH, Liu CH.
    Zhongguo Zhong Yao Za Zhi; 2015 Mar 26; 40(6):1166-72. PubMed ID: 26226765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet () and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical Trial.
    Li ZX, Zhao ZM, Liu P, Zheng QS, Liu CH.
    Chin J Integr Med; 2021 Jul 26; 27(7):509-513. PubMed ID: 32572776
    [Abstract] [Full Text] [Related]

  • 11. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components.
    Yang T, Shen DP, Wang QL, Tao YY, Liu CH.
    J Ethnopharmacol; 2013 Jul 09; 148(2):691-700. PubMed ID: 23707207
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis.
    Sun X, Tan Y, Lyu J, Liu HL, Zhao ZM, Liu CH.
    Chin J Integr Med; 2022 Jun 09; 28(6):538-544. PubMed ID: 34581939
    [Abstract] [Full Text] [Related]

  • 15. [Effect of Fuzheng Huayu capsule on serum metabolomics in rats with liver fibrosis induced by dimethylnitrosamine].
    Gao GY, Zheng XY, Peng Y, Tao YY, Liu P, Yang T, Liu CH.
    Zhongguo Zhong Yao Za Zhi; 2016 May 09; 41(9):1725-1731. PubMed ID: 28891625
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R, Guo J, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Li M, Xie Y.
    Clin Exp Med; 2019 Aug 09; 19(3):309-320. PubMed ID: 31111345
    [Abstract] [Full Text] [Related]

  • 19. Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.
    Xie H, Tao Y, Lv J, Liu P, Liu C.
    Evid Based Complement Alternat Med; 2013 Aug 09; 2013():972863. PubMed ID: 23431353
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.